Back to Results
First PageMeta Content
Amyotrophic lateral sclerosis / ALS Therapy Development Institute / Medicine / Chemistry / SOD1 / Riluzole / Augie Nieto / Minocycline / Creatine / Health / Rare diseases / Motor neurone disease


Media Contacts Sean A. Scott, President ALS Therapy Development Institute[removed]removed] Charles Versaggi, Ph.D.
Add to Reading List

Document Date: 2008-02-05 13:21:33

Open Document

File Size: 109,03 KB

Share Result on Facebook

City

CAMBRIDGE / /

Company

ALS Therapy Development Institute / /

Continent

Europe / /

Country

United States / /

Currency

pence / USD / /

/

Event

Labor Issues / /

Facility

About ALS Therapy Development Institute The ALS Therapy Development Institute / Cambridge-based ALS Therapy Development Institute / ALS Therapy Development Institute / /

IndustryTerm

biotechnology / data mining / Internet edition / /

MedicalCondition

paralysis / Lou Gehrig’s Disease / disease / respiratory failure / chronic / progressive neurodegenerative disease / neuromuscular diseases / ALS / novel disease / amyotrophic lateral sclerosis / /

Organization

Muscular Dystrophy Association / U.S. Food and Drug Administration / ALS Therapy Development Institute / /

Person

Charles Versaggi / Sharon Hesterlee / Sean A. Scott / Lou Gehrig / Augie Nieto / /

/

Position

chairman / President / vice president / translational research / principal investigator and president / /

Product

riluzole / ceftriaxone / /

ProvinceOrState

Massachusetts / /

Technology

biotechnology / data mining / /

URL

www.als.net / /

SocialTag